Rabin Martin, a privately owned company headquartered in the United States and owned by Omnicom PR Group (OPRG), operates as an advertising, marketing, and media agency with approximately 50 employees. The firm functions as consultants focused on driving health outcomes, access, and equity, providing services from strategy to execution. It designs, develops, and delivers solutions aimed at unlocking new markets and opportunities, facilitating access to client medicines and vaccines, and generating support among key stakeholders. The company leverages global health expertise and partnerships, with experience spanning commercial strategy, health system strengthening, health equity, and therapeutic areas such as cancer, chronic disease, rare diseases, and maternal and child health. Rabin Martin utilizes local market knowledge, policy, and partnerships to influence business and public health outcomes. Its client base includes entities within the UN, pharmaceutical companies like J&J and Takeda, and foundations such as Rockefeller and Bill & Melinda Gates. The firm has managed over $2 billion in health programming across 80 markets, including the US, Europe, and Low-to-Middle Income Countries, managing everything from strategy and solution development through to implementation, measurement, and evaluation.